Sponsors (2)
The bill improves consumer safety and marketplace transparency by preventing non-egg products from using egg market names and reaffirming eggs' nutritional role, but it imposes compliance and rebranding costs on plant-based producers, may limit naming/innovation and consumer choice, and requires agency enforcement.
People with egg allergies and general shoppers (consumers) will be less likely to be misled because products that contain no real eggs cannot use egg market names, improving point-of-purchase transparency and reducing accidental exposures.
Low-income households, parents, and infants benefit from reaffirming eggs as an inexpensive, nutrient-dense protein — including choline and long-chain PUFAs — which supports infant brain development and affordable access to key nutrients.
Producers that actually use eggs and manufacturers who meet the new naming/ingredient criteria gain clearer marketplace differentiation and reduced unfair competition from products that previously used 'egg' names despite containing no eggs.
Manufacturers of plant-based or alternative products will likely face compliance, relabeling, and rebranding costs — expenses that can be passed to consumers as higher prices or that strain small producers' budgets.
Restricting use of 'egg' market names may limit naming options for innovators, stigmatize some plant-based alternatives, reduce product variety or perceived choice, and cause short-term confusion during product renaming.
Emphasizing eggs' nutritional advantages could discourage some consumers — including budget-conscious shoppers — from choosing plant-based alternatives, potentially narrowing affordable diet options for certain groups.
Based on analysis of 4 sections of legislative text.
Introduced September 30, 2025 by Elise M. Stefanik · Last progress September 30, 2025
Prohibits labeling or marketing a food with any egg or egg-product market name unless the food actually meets a statutory definition of an egg or egg product. It adds a new misbranding rule to the Federal Food, Drug, and Cosmetic Act, defines what counts as an “egg” and an “egg product,” and ties covered market names to existing federal regulations. The bill requires the FDA to issue draft guidance within 180 days and final guidance within one year, cancels any prior inconsistent FDA guidance, and requires a two-year report to Congress describing enforcement actions and any remaining misbranded products in commerce.